Astec LifeSciences Limited — Important, 15-03-2025: General Updates

A Special Resolution has been passed by shareholders, approving the re-appointment of Mr. Rishinaradamangalam Ramakrishna Govindan as an Independent Director for a term from 30th January 2025 to 12th August 2029. Mr. Govindan is not barred from serving as a Director by SEBI or any other authority. The Scrutinizer's report will be made available on the company’s website, providing shareholders transparency regarding the voting process. This leadership decision could enhance governance and strategic oversight, positively influencing investor confidence.